Sectoral Asset Management
Latest statistics and disclosures from Sectoral Asset Management's latest quarterly 13F-HR filing:
- Top 5 stock holdings are AVIR, ARVN, TNDM, TDOC, LH, and represent 16.62% of Sectoral Asset Management's stock portfolio.
- Added to shares of these 10 stocks: AVIR (+$62M), MRVI (+$28M), REPL (+$26M), TNDM (+$24M), CERT (+$20M), RCKT (+$20M), EXEL (+$19M), TDOC (+$19M), ZBH (+$19M), MRTX (+$16M).
- Started 25 new stock positions in REPL, MRTX, ZBH, HZNP, NTRA, SHC, SGTX, KOD, OSH, MRVI.
- Reduced shares in these 10 stocks: Immunomedics (-$51M), , ZNTL (-$18M), BPMC (-$18M), ASMB (-$15M), ARVN (-$14M), FOLD (-$14M), GBT (-$14M), BSX (-$12M), INCY (-$11M).
- Sold out of its positions in AMED, ASMB, CSTL, CHNG, DYN, EBS, GBIO, GBT, HMSY, HUM. Immunomedics, OM, Seattle Genetics, TRHC, TSHA, ZNTL.
- Sectoral Asset Management was a net buyer of stock by $99M.
- Sectoral Asset Management has $1.4B in assets under management (AUM), dropping by 22.01%.
- Central Index Key (CIK): 0001274413
Tip: Access up to 7 years of quarterly data
Positions held by Sectoral Asset Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Portfolio Holdings for Sectoral Asset Management
Companies in the Sectoral Asset Management portfolio as of the December 2020 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price | |
|---|---|---|---|---|---|---|
| Atea Pharmaceuticals (AVIR) | 4.4 | $62M | NEW | 1.5M | 41.78 | |
| Arvinas Ord (ARVN) | 3.2 | $45M | -24% | 532k | 84.93 | |
| Tandem Diabetes Care Com New (TNDM) | 3.2 | $45M | +111% | 472k | 95.68 | |
| Teladoc (TDOC) | 3.0 | $42M | +80% | 210k | 199.96 | |
| Laboratory Corp Amer Hldgs Com New (LH) | 2.9 | $41M | +15% | 202k | 203.55 | |
| Ptc Therapeutics I (PTCT) | 2.6 | $37M | -9% | 604k | 61.03 | |
| Exelixis (EXEL) | 2.5 | $36M | +110% | 1.8M | 20.07 | |
| AtriCure (ATRC) | 2.5 | $36M | -9% | 644k | 55.67 | |
| Teleflex Incorporated (TFX) | 2.5 | $36M | +18% | 86k | 411.56 | |
| Amicus Therapeutics (FOLD) | 2.5 | $35M | -28% | 1.5M | 23.09 | |
| ACADIA Pharmaceuticals (ACAD) | 2.5 | $35M | +17% | 654k | 53.46 | |
| Ppd (PPD) | 2.4 | $33M | 977k | 34.22 | ||
| Evolent Health Cl A (EVH) | 2.3 | $33M | 2.0M | 16.03 | ||
| Turning Point Therapeutics I (TPTX) | 2.2 | $31M | +2% | 257k | 121.85 | |
Setup an alertSectoral Asset Management will file the next quarterly 13-HR in about 1 months. Would you like to be notified? |
||||||
| Acutus Medical (AFIB) | 2.0 | $28M | +84% | 982k | 28.81 | |
| R1 Rcm (RCM) | 2.0 | $28M | -23% | 1.2M | 24.02 | |
| Deciphera Pharmaceuticals (DCPH) | 2.0 | $28M | +17% | 489k | 57.07 | |
| Maravai Lifesciences Hldgs I Com Cl A (MRVI) | 1.9 | $28M | NEW | 979k | 28.05 | |
| Replimune Group (REPL) | 1.8 | $26M | NEW | 668k | 38.15 | |
| Irhythm Technologies (IRTC) | 1.8 | $25M | +2% | 107k | 237.21 | |
| Silk Road Medical Inc Common (SILK) | 1.8 | $25M | +2% | 400k | 62.98 | |
| Novavax Com New (NVAX) | 1.8 | $25M | +88% | 223k | 111.51 | |
| Align Technology (ALGN) | 1.7 | $25M | +27% | 46k | 534.39 | |
| Arena Pharmaceuticals Com New (ARNA) | 1.7 | $25M | -21% | 320k | 76.83 | |
| Repligen Corporation (RGEN) | 1.7 | $24M | +21% | 124k | 191.63 | |
| IDEXX Laboratories (IDXX) | 1.7 | $24M | +15% | 47k | 499.86 | |
| Arcus Biosciences Com Usd (RCUS) | 1.6 | $22M | -6% | 861k | 25.96 | |
| Certara Ord (CERT) | 1.4 | $20M | NEW | 606k | 33.72 | |
| Rocket Pharmaceuticals (RCKT) | 1.4 | $20M | NEW | 367k | 54.84 | |
| Zimmer Holdings (ZBH) | 1.3 | $19M | NEW | 121k | 154.09 | |
| American Well Corp Cl A (AMWL) | 1.3 | $18M | +19% | 724k | 25.33 | |
| Pra Health Sciences Com Usd (PRAH) | 1.2 | $17M | +3% | 137k | 125.44 | |
| Mirati Therapeutics (MRTX) | 1.1 | $16M | NEW | 74k | 219.64 | |
| Dex (DXCM) | 1.1 | $16M | -12% | 43k | 369.71 | |
| Revolution Medicines (RVMD) | 1.1 | $15M | -38% | 389k | 39.59 | |
| Centene Corporation (CNC) | 1.1 | $15M | -34% | 257k | 60.03 | |
| Blueprint Medicines (BPMC) | 1.1 | $15M | -53% | 137k | 112.15 | |
| Oak Street Health (OSH) | 1.1 | $15M | NEW | 250k | 61.16 | |
| Sarepta Therapeutics (SRPT) | 1.0 | $15M | -6% | 87k | 170.50 | |
| ResMed (RMD) | 1.0 | $14M | -8% | 66k | 212.56 | |
| Alnylam Pharmaceuticals (ALNY) | 1.0 | $14M | NEW | 108k | 129.97 | |
| Alexion Pharmaceuticals (ALXN) | 1.0 | $14M | +71% | 88k | 156.24 | |
| Moderna (MRNA) | 0.9 | $13M | -7% | 126k | 104.47 | |
| Freeline Therapeutics Hldgs Sponsored Ads (FRLN) | 0.8 | $12M | -21% | 658k | 18.26 | |
| Johnson & Johnson (JNJ) | 0.8 | $12M | 75k | 157.38 | ||
| Hologic (HOLX) | 0.8 | $12M | +3% | 158k | 72.83 | |
| Insulet Corporation (PODD) | 0.8 | $11M | -4% | 43k | 255.64 | |
| Sigilon Therapeutics (SGTX) | 0.8 | $11M | NEW | 225k | 48.03 | |
| Tg Therapeutics (TGTX) | 0.8 | $11M | NEW | 207k | 52.02 | |
| Abbvie (ABBV) | 0.7 | $10M | +10% | 95k | 107.15 | |
| Guardant Health (GH) | 0.7 | $10M | 79k | 128.88 | ||
| Seagen (SGEN) | 0.7 | $10M | NEW | 58k | 175.15 | |
| Poseida Therapeutics I (PSTX) | 0.6 | $9.2M | -20% | 839k | 10.97 | |
| Bristol Myers Squibb (BMY) | 0.6 | $9.0M | -26% | 146k | 62.03 | |
| Fate Therapeutics (FATE) | 0.6 | $9.0M | NEW | 99k | 90.93 | |
| UnitedHealth (UNH) | 0.6 | $8.9M | 26k | 350.68 | ||
| Cytosorbents Corp Com New (CTSO) | 0.6 | $8.8M | -32% | 1.1M | 7.97 | |
| Natera (NTRA) | 0.6 | $8.8M | NEW | 88k | 99.52 | |
| Abbott Laboratories (ABT) | 0.6 | $8.7M | +8% | 80k | 109.49 | |
| Eli Lilly & Co. (LLY) | 0.6 | $8.7M | 52k | 168.84 | ||
| BioMarin Pharmaceutical (BMRN) | 0.6 | $8.5M | -36% | 97k | 87.69 | |
| Molina Healthcare (MOH) | 0.6 | $8.1M | -33% | 38k | 212.68 | |
| Checkmate Pharmaceuticals In (CMPI) | 0.6 | $8.0M | -8% | 549k | 14.59 | |
| Aveo Pharmaceuticals Com New (AVEO) | 0.5 | $6.6M | +1051% | 1.2M | 5.77 | |
| Cigna Corp (CI) | 0.4 | $5.8M | +9% | 28k | 208.18 | |
| Seer Com Cl A (SEER) | 0.4 | $5.3M | NEW | 95k | 56.14 | |
| Bellus Health Com New (BLU) | 0.4 | $5.2M | NEW | 1.7M | 3.06 | |
| Amgen (AMGN) | 0.4 | $5.2M | -7% | 23k | 229.90 | |
| Thermo Fisher Scientific (TMO) | 0.3 | $4.8M | +20% | 10k | 465.77 | |
| Medtronic SHS (MDT) | 0.3 | $4.5M | -7% | 39k | 117.14 | |
| Vertex Pharmaceuticals Incorporated (VRTX) | 0.3 | $4.0M | +71% | 17k | 236.33 | |
| Fibrogen (FGEN) | 0.3 | $3.9M | 104k | 37.09 | ||
| Crispr Therapeutics Namen Akt (CRSP) | 0.3 | $3.8M | NEW | 25k | 153.10 | |
| Apellis Pharmaceuticals (APLS) | 0.3 | $3.7M | NEW | 65k | 57.20 | |
| Merck & Co (MRK) | 0.3 | $3.6M | -11% | 45k | 81.80 | |
| Pfizer (PFE) | 0.2 | $3.5M | -15% | 95k | 36.81 | |
| Nucana Sponsored Adr (NCNA) | 0.2 | $3.4M | 750k | 4.49 | ||
| Biogen Idec (BIIB) | 0.2 | $3.1M | -43% | 13k | 244.88 | |
| Regeneron Pharmaceuticals (REGN) | 0.2 | $2.2M | -79% | 4.6k | 483.12 | |
| Molecular Templates (MTEM) | 0.1 | $2.1M | +25% | 225k | 9.39 | |
| Sotera Health (SHC) | 0.1 | $2.0M | NEW | 75k | 27.45 | |
| Stryker Corporation (SYK) | 0.1 | $1.9M | NEW | 7.8k | 245.00 | |
| Boston Scientific Corporation (BSX) | 0.1 | $1.8M | -86% | 50k | 35.96 | |
| Gilead Sciences (GILD) | 0.1 | $1.7M | -54% | 30k | 58.27 | |
| Danaher Corporation (DHR) | 0.1 | $1.7M | 7.5k | 222.13 | ||
| Illumina (ILMN) | 0.1 | $1.5M | -15% | 4.1k | 370.02 | |
| Aprea Therapeutics (APRE) | 0.1 | $805k | -82% | 164k | 4.92 | |
| Incyte Corporation (INCY) | 0.1 | $752k | -93% | 8.6k | 87.04 | |
| Argenx Se Sponsored Adr (ARGX) | 0.1 | $735k | 2.5k | 294.00 | ||
| Horizon Therapeutics Pub L SHS (HZNP) | 0.0 | $693k | NEW | 9.5k | 73.14 | |
| Zai Lab Adr (ZLAB) | 0.0 | $528k | +44% | 3.9k | 135.38 | |
| Aligos Therapeutics (ALGS) | 0.0 | $517k | NEW | 19k | 27.64 | |
| Dr Reddys Labs Adr (RDY) | 0.0 | $460k | +20% | 6.5k | 71.27 | |
| Bridgebio Pharma (BBIO) | 0.0 | $427k | NEW | 6.0k | 71.17 | |
| Allovir Com Usd (ALVR) | 0.0 | $375k | -96% | 9.7k | 38.48 | |
| Kodiak Sciences (KOD) | 0.0 | $242k | NEW | 1.7k | 146.67 | |
| 4d Molecular Therapeutics In (FDMT) | 0.0 | $217k | NEW | 5.2k | 41.54 | |
Past Filings by Sectoral Asset Management
SEC 13F filings are viewable for Sectoral Asset Management going back to 2010
- Sectoral Asset Management 2020 Q4 filed Feb. 12, 2021
- Sectoral Asset Management 2020 Q3 filed Nov. 13, 2020
- Sectoral Asset Management 2020 Q2 filed Aug. 13, 2020
- Sectoral Asset Management 2020 Q1 filed May 13, 2020
- Sectoral Asset Management 2019 Q4 filed Feb. 12, 2020
- Sectoral Asset Management 2019 Q3 filed Nov. 14, 2019
- Sectoral Asset Management 2019 Q2 filed Aug. 14, 2019
- Sectoral Asset Management 2019 Q1 filed May 14, 2019
- Sectoral Asset Management 2018 Q4 filed Feb. 12, 2019
- Sectoral Asset Management 2018 Q3 filed Nov. 14, 2018
- Sectoral Asset Management 2018 Q2 filed Aug. 13, 2018
- Sectoral Asset Management 2018 Q1 filed May 15, 2018
- Sectoral Asset Management 2017 Q4 filed Feb. 13, 2018
- Sectoral Asset Management 2017 Q3 filed Nov. 14, 2017
- Sectoral Asset Management 2017 Q2 filed Aug. 14, 2017
- Sectoral Asset Management 2017 Q1 filed May 15, 2017